>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>β-Nicotinamide adenine dinucleotide reduced dipotassium

β-Nicotinamide adenine dinucleotide reduced dipotassium

Catalog No.GC67484

β-니코틴아미드 아데닌 디뉴클레오티드 환원 디칼륨은 경구 활성 환원 조효소입니다. 821d96072c2d58d8970e76f526b0f6b8β-니코틴아미드 아데닌 디뉴클레오티드 환원된 이칼륨은 ADP-리보실라톤 반응에서 ADP-리보스 단위의 기증자이며 사이클릭 ADP-리보스의 전구체입니다. 821d96072c2d58d8970e76f526b0f6b8β-니코틴아미드 아데닌 디뉴클레오티드 환원된 이칼륨은 해당작용, β-산화 및 트리카르복실산(TCA) 주기를 포함하는 세포 에너지 대사에서 재생 전자 공여체 역할을 합니다.821d96072c2d58d8970e76f526b0f6b8

Products are for research use only. Not for human use. We do not sell to patients.

β-Nicotinamide adenine dinucleotide reduced dipotassium Chemical Structure

Cas No.: 104809-32-7

Size 가격 재고 수량
25mg
US$145.00
재고 있음
100mg
US$572.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

β-Nicotinamide adenine dinucleotide reduced dipotassium is an orally active reduced coenzyme. β-Nicotinamide adenine dinucleotide reduced dipotassium is a donor of ADP-ribose units in ADP-ribosylaton reactions and a precursor of cyclic ADP-ribose. β-Nicotinamide adenine dinucleotide reduced dipotassium plays a role as a regenerative electron donor in cellular energy metabolism, including glycolysis, β-oxidation and the tricarboxylic acid (TCA) cycle[1].

[1]. Ying W. NAD+ and NADH in cellular functions and cell death. Front Biosci. 2006 Sep 1;11:3129-48.

리뷰

Review for β-Nicotinamide adenine dinucleotide reduced dipotassium

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-Nicotinamide adenine dinucleotide reduced dipotassium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.